These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7481788)

  • 1. Monoclonal antibodies at age 20: promise at last?
    Hall SS
    Science; 1995 Nov; 270(5238):915-6. PubMed ID: 7481788
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of monoclonal antibodies in cancer therapy: present and promise.
    Stern M; Herrmann R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in tumor therapy.
    Matzku S
    Recent Results Cancer Res; 1996; 141():1-8. PubMed ID: 8722416
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibodies: the good, the bad, and the ugly.
    Myint H
    J Hematother Stem Cell Res; 2003 Feb; 12(1):3-6. PubMed ID: 12662429
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N
    Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease.
    Hank JA; Albertini MR; Sondel PM
    Cancer Chemother Biol Response Modif; 1999; 18():210-22. PubMed ID: 10800484
    [No Abstract]   [Full Text] [Related]  

  • 9. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 10. Engineering antibodies for clinical applications in cancer.
    Chester K; Pedley B; Tolner B; Violet J; Mayer A; Sharma S; Boxer G; Green A; Nagl S; Begent R
    Tumour Biol; 2004; 25(1-2):91-8. PubMed ID: 15192316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
    Stipsanelli E; Valsamaki P
    Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptides and monoclonal antibodies in oncology: an introduction.
    de Jong M; Boerman OC; Krenning EP
    Cancer Biother Radiopharm; 2003 Aug; 18(4):591-2. PubMed ID: 14503954
    [No Abstract]   [Full Text] [Related]  

  • 14. MoAb A33 shows promise in targeting colon cancer for radioimmunotherapy.
    Oncology (Williston Park); 1996 Apr; 10(4):553. PubMed ID: 8723287
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibody therapy.
    Schwartz MA; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1992; 13():156-74. PubMed ID: 1389908
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009).
    Goffredo V; Paradiso A; Ranieri G; Gadaleta CD
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):393-410. PubMed ID: 21388824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies.
    Williams LE; Liu A; Wu AM; Odom-Maryon T; Chai A; Raubitschek AA; Wong JY
    Med Phys; 1995 Dec; 22(12):2025-7. PubMed ID: 8746707
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the Applications of Monoclonal Antibodies in Clinical Oncology. Proceedings of a meeting. Paphos, Cyprus, May 3-5, 1993.
    Cell Biophys; 1994; 24-25():1-343. PubMed ID: 7736512
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor targeting with monoclonal antibodies. Advances in the Applications of Monoclonal Antibodies in Clinical Oncology, symposium. Porto Carras, Halkidiki, Greece, May 4-6, 1992.
    Cell Biophys; 1993; 22(1-3):1-246. PubMed ID: 7889534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.